Explains about responses to a drug, challenges in Adverse Drug Reaction Reporting. For more information visit: http://www.transformhealth-it.org/

1. 1
ADVERSE DRUG REACTION
REPORTING AND MONITORING
SOFTWARE

2. 2
HELLO,
I’m Mammen Paul
CONCEPT DEVELOPMENTDESIGN

3. 3

4. 4

5. 5
INTRODUCTION

6. 6
A D V E R S E D R U G
R E A C T I O N ?
Adverse Drug Reactions are responses to a drug, which are noxious
and unintended, and which occurs at doses normally used in man for
the prophylaxis, diagnosis, or therapy of disease or for the
modifications of physiological function.

7. 7
CHALLENGES IN ADVERSE DRUG REACTION
REPORTING
COMMUNICATION
ANALYSIS
TIME
CONSUMPTION
UNAWARENESS
DATA
RETRIEVAL
STORAGE
DOCUMENTATION

8. 8
INNOVATION

9. 9
INNOVATION
The challenges faced and the need for a
better pharmacovigilance are the
motivation behind the development of
this software.PLANNING
Selection of programming language.
Modules to be included.
Structuring database.
DESIGN / DEVELOP
• Front end – Microsoft Visual Studio
2008
• Back end – SQL Server 2008
M E T H O D S &
R E S U L T S

10. 10
STRATEGY
• Dashboard and shortcuts - user-friendly.
• Dynamic nature of software – improves
functionality.
• Automatic E-mails - communication of ADR.EVALUATION/TWEAKING
Live test were performed by students and
staffs of Al-Shifa College of Pharmacy.
Tweaks were performed based on live
test.
CHALLENGES FACED
Making a user friendly design.
Improving functionality.
Communication of ADR with physicians.

11. 11
FEATURES

12. 12
F E A T U R E S
ADR REPORTING MODULE
ADVANCED SEARCH
REPORTS (SOFT/HARDCOPY)
E-MAIL PHYSICIAN
NARANJO SCALE

13. 13

14. 14

15. 15

16. 16
CONCLUSION

17. 17
In essence the ADR reporting and monitoring
software is embedded with lots of features
that can be used in hospitals and other
healthcare facilities for better
pharmacovigilance.

18. 18
NEXT STEP

19. 19
NATIONAL PHARMACOVIGILANCE PROGRAM
• The implementation of this software in
healthcare facilities can advance
pharmacovigilance in our country.
• The software has the potential to become the
backbone of National Pharmacovigilance
Program.
R O A D
A H E A D

20. 20
F L Y H I G H , W H E R E N O B O D Y C A N T O U C H Y O U !
If you have the wits to chase your dreams nobody can stop you.
THANK YOU!